Chesapeake Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.5M | Buy |
9,659
+349
| +4% | +$357K | 8.81% | 1 |
|
|
2026
Q1 | $8.56M | Buy |
9,310
+152
| +2% | +$154K | 6.79% | 2 |
|
|
2025
Q4 | $9.84M | Buy |
9,158
+290
| +3% | +$277K | 8.13% | 2 |
|
|
2025
Q3 | $6.77M | Sell |
8,868
-31
| -0.3% | -$23.1K | 5.99% | 3 |
|
|
2025
Q2 | $6.94M | Sell |
8,899
-37
| -0.4% | -$28.8K | 6.24% | 2 |
|
|
2025
Q1 | $7.38M | Buy |
8,936
+78
| +0.9% | +$64.9K | 6.95% | 2 |
|
|
2024
Q4 | $6.84M | Sell |
8,858
-734
| -8% | -$608K | 6.37% | 3 |
|
|
2024
Q3 | $8.5M | Buy |
9,592
+27
| +0.3% | +$24.3K | 7.38% | 2 |
|
|
2024
Q2 | $8.66M | Sell |
9,565
-8
| -0.1% | -$6.4K | 8.28% | 2 |
|
|
2024
Q1 | $7.45M | Sell |
9,573
-787
| -8% | -$560K | 7.36% | 2 |
|
|
2023
Q4 | $6.04M | Buy |
10,360
+98
| +1% | +$57.2K | 5.38% | 3 |
|
|
2023
Q3 | $5.51M | Buy |
10,262
+207
| +2% | +$107K | 5.34% | 3 |
|
|
2023
Q2 | $4.72M | Sell |
10,055
-1,133
| -10% | -$475K | 4.25% | 4 |
|
|
2023
Q1 | $3.84M | Buy |
+11,188
| New | +$3.77M | 3.51% | 6 |
|
|
2019
Q4 | $2.47M | Hold |
18,774
| – | – | 4.18% | 8 |
|
|
2019
Q3 | $2.1M | Sell |
18,774
-1,516
| -7% | -$169K | 3.95% | 10 |
|
|
2019
Q2 | $2.25M | Hold |
20,290
| – | – | 3.71% | 10 |
|
|
2019
Q1 | $2.63M | Sell |
20,290
-2,555
| -11% | -$311K | 4.48% | 8 |
|
|
2018
Q4 | $2.64M | Sell |
22,845
-350
| -2% | -$39.1K | 4.87% | 7 |
|
|
2018
Q3 | $2.49M | Sell |
23,195
-100
| -0.4% | -$10K | 2.86% | 12 |
|
|
2018
Q2 | $1.99M | Sell |
23,295
-575
| -2% | -$47.2K | 2.32% | 15 |
|
|
2018
Q1 | $1.85M | Sell |
23,870
-535
| -2% | -$43.1K | 1.98% | 16 |
|
|
2017
Q4 | $2.06M | Sell |
24,405
-1,310
| -5% | -$111K | 1.99% | 17 |
|
|
2017
Q3 | $2.2M | Hold |
25,715
| – | – | 1.98% | 15 |
|
|
2017
Q2 | $2.12M | Sell |
25,715
-640
| -2% | -$52.2K | 2.01% | 16 |
|
|
2017
Q1 | $2.22M | Sell |
26,355
-920
| -3% | -$73.7K | 1.83% | 18 |
|
|
2016
Q4 | $2.01M | Hold |
27,275
| – | – | 1.74% | 22 |
|
|
2016
Q3 | $2.19M | Hold |
27,275
| – | – | 1.98% | 19 |
|
|
2016
Q2 | $2.15M | Sell |
27,275
-2,350
| -8% | -$177K | 1.75% | 20 |
|
|
2016
Q1 | $2.13M | Hold |
29,625
| – | – | 1.77% | 22 |
|
|
2015
Q4 | $2.5M | Sell |
29,625
-225
| -0.8% | -$18.7K | 1.92% | 21 |
|
|
2015
Q3 | $2.5M | Hold |
29,850
| – | – | 2.12% | 19 |
|
|
2015
Q2 | $2.49M | Hold |
29,850
| – | – | 1.83% | 21 |
|
|
2015
Q1 | $2.17M | Hold |
29,850
| – | – | 1.6% | 27 |
|
|
2014
Q4 | $2.06M | Sell |
29,850
-300
| -1% | -$20.3K | 1.29% | 35 |
|
|
2014
Q3 | $1.96M | Hold |
30,150
| – | – | 1.19% | 37 |
|
|
2014
Q2 | $1.87M | Hold |
30,150
| – | – | 1.16% | 35 |
|
|
2014
Q1 | $1.77M | Hold |
30,150
| – | – | 1.2% | 38 |
|
|
2013
Q4 | $1.54M | Hold |
30,150
| – | – | 0.91% | 43 |
|
|
2013
Q3 | $1.52M | Sell |
30,150
-968
| -3% | -$50.7K | 1.02% | 39 |
|
|
2013
Q2 | $1.53M | Buy |
+31,118
| New | +$1.69M | 1.1% | 40 |
|
Other funds holding LLY
Chesapeake Asset Management's LLY Position: Q2 2026 in Review
Chesapeake Asset Management increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $357K and bringing the position to 9,659 shares worth $11.5M. The position accounts for 8.81% of the portfolio, ranked #1.
Chesapeake Asset Management first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Chesapeake Asset Management held 9,659 shares of Eli Lilly worth $11.5M as of Q2 2026.
- Chesapeake Asset Management bought 349 Eli Lilly shares in Q2 2026, an estimated $357K.
- Eli Lilly made up 8.81% of Chesapeake Asset Management's portfolio in Q2 2026, its #1 holding.
- Chesapeake Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.